BIO-TECHNE Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BIO-TECHNE Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.22B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.16B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $1.14B | Aug 22, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.22B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.16B | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $1.14B | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $1.11B | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $931.03M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $738.69M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $714.01M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $642.99M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $563.00M | Nov 6, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $156.58M | Sep 7, 2017 |
| FY2017 | Mar 31, 2017 | $144.04M | Sep 7, 2017 |
| FY2017 | Dec 31, 2016 | $131.81M | Sep 7, 2017 |
| FY2017 | Sep 30, 2016 | $130.58M | Sep 7, 2017 |
| FY2017 | Jun 30, 2016 | $134.76M | Sep 7, 2017 |
| FY2017 | Mar 31, 2016 | $130.97M | Sep 7, 2017 |
| FY2017 | Dec 31, 2015 | $120.91M | Sep 7, 2017 |
| FY2017 | Sep 30, 2015 | $112.38M | Sep 7, 2017 |
| FY2017 | Jun 30, 2015 | $452.25M | Sep 7, 2017 |
| FY2016 | Jun 30, 2014 | $357.76M | Aug 29, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $790.27M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $769.73M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $769.82M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $756.50M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $632.85M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $483.19M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $473.49M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $432.14M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $374.54M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $336.66M | Aug 27, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $73.40M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $168.11M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $285.26M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $272.05M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $140.41M | Aug 23, 2023 |
| FY2020 | Jun 30, 2020 | $58.85M | Aug 26, 2020 |
| FY2020 | Mar 31, 2020 | $36.43M | Aug 26, 2020 |
| FY2020 | Dec 31, 2019 | $119.62M | Aug 26, 2020 |
| FY2020 | Sep 30, 2019 | $14.40M | Aug 26, 2020 |
| FY2020 | Jun 30, 2019 | $16.46M | Aug 26, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $102.26M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $206.69M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $298.94M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $296.59M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $237.30M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $157.42M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $146.72M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $136.18M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $120.58M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $150.59M | Aug 27, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $588.52M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $466.38M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $378.38M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $372.77M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $324.95M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $260.58M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $264.36M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $240.64M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $200.44M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $140.88M | Aug 27, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $287.56M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $298.98M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $254.39M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $325.27M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $352.16M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $205.22M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $181.62M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $170.37M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $143.72M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $144.16M | Aug 27, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $31.01M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $62.88M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $38.24M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $44.91M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $44.30M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $51.74M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $25.41M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $20.93M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $15.18M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $16.90M | Aug 27, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $2.56B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $2.70B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $2.64B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $2.29B | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $2.26B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $2.03B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $1.88B | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $1.59B | Nov 6, 2019 |
| FY2018 | Jun 30, 2017 | $1.56B | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | $1.13B | Sep 7, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | $2.07B | Aug 22, 2024 |
| FY2024 | Jun 30, 2023 | $1.97B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $1.70B | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $1.56B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $1.38B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $1.17B | Aug 26, 2020 |
| FY2020 | Jun 30, 2018 | $1.08B | Aug 26, 2020 |
| FY2020 | Jun 30, 2017 | $949.63M | Aug 26, 2020 |
| FY2019 | Jun 30, 2016 | $879.28M | Nov 6, 2019 |
| FY2018 | Jun 30, 2015 | $846.94M | Aug 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $980.94M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $972.66M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $872.74M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $822.10M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $843.07M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $728.31M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $732.67M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $597.89M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $579.03M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $430.88M | Aug 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $1.07B | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $1.33B | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $1.31B | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $1.12B | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $1.09B | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $1.06B | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $931.93M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $876.93M | Nov 6, 2019 |
| FY2018 | Jun 30, 2017 | $799.03M | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | $770.55M | Sep 7, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $162.19M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $151.79M | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | $180.57M | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | $172.57M | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | $199.09M | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | $146.63M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | $100.89M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | $121.99M | Nov 6, 2019 |
| FY2019 | Jun 30, 2017 | $91.61M | Nov 6, 2019 |
| FY2019 | Jun 30, 2016 | $64.24M | Nov 6, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | 1 | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 23, 2023 |
| FY2020 | Jun 30, 2020 | 1 | Aug 26, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 26, 2020 |
| FY2020 | Dec 31, 2019 | 3 | Aug 26, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 26, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 26, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 1 | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | 1 | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | 1 | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | 0 | Aug 23, 2023 |
| FY2020 | Jun 30, 2020 | 1 | Aug 26, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Aug 26, 2020 |
| FY2020 | Dec 31, 2019 | 3 | Aug 26, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Aug 26, 2020 |
| FY2020 | Jun 30, 2019 | 0 | Aug 26, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 154.97M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | 158.22M | Aug 22, 2025 |
| FY2024 | Jun 30, 2023 | 157.64M | Aug 22, 2024 |
| FY2023 | Jun 30, 2022 | 156.64M | Aug 23, 2023 |
| FY2022 | Jun 30, 2021 | 38.96M | Aug 24, 2022 |
| FY2021 | Jun 30, 2020 | 38.45M | Aug 25, 2021 |
| FY2020 | Jun 30, 2019 | 37.93M | Aug 26, 2020 |
| FY2019 | Jun 30, 2018 | 37.61M | Nov 6, 2019 |
| FY2018 | Jun 30, 2017 | 37.36M | Aug 27, 2018 |
| FY2017 | Jun 30, 2016 | 37.25M | Sep 7, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $50.39M | Aug 22, 2025 |
| FY2025 | Jun 30, 2024 | $50.42M | Aug 22, 2025 |
| FY2025 | Jun 30, 2023 | $50.29M | Aug 22, 2025 |
| FY2024 | Jun 30, 2022 | $50.19M | Aug 22, 2024 |
| FY2023 | Jun 30, 2021 | $49.62M | Aug 23, 2023 |
| FY2022 | Jun 30, 2020 | $48.90M | Aug 24, 2022 |
| FY2021 | Jun 30, 2019 | $48.36M | Aug 25, 2021 |
| FY2020 | Jun 30, 2018 | $47.97M | Aug 26, 2020 |
| FY2019 | Jun 30, 2017 | $47.33M | Nov 6, 2019 |
| FY2018 | Jun 30, 2016 | $47.61M | Aug 27, 2018 |